Literature DB >> 24930676

An overview of visceral leishmaniasis elimination program in India: a picture imperfect.

Ubhayabharathi Gurunath1, Rayanta Joshi, Ashish Agrawal, Vatsal Shah.   

Abstract

Visceral leishmaniasis (VL) has been one of the most neglected tropical diseases in India. Concurrent and correct data on the burden of VL is vital to plan, allocate trained resources and to monitor the progress of the elimination program. More emphasis on integrated vector management can help in combating the disease spread. Effective surveillance, active and accurate diagnosis using rK39 strip test and use of an affordable, safe and efficient treatment option like liposomal amphotericin B remain the key components of VL control. Sustained advocacy, information, education and communication are needed in all the endemic areas. In this paper, we review the effectiveness of the strategies adopted in VL elimination in India.

Entities:  

Keywords:  elimination in India; indicator; integrated vector management; kala-azar; visceral leishmaniasis

Mesh:

Substances:

Year:  2014        PMID: 24930676     DOI: 10.1586/14787210.2014.928590

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

1.  Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.

Authors:  H V Y D Siriwardana; P Karunanayake; L Goonerathne; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2017-08-18       Impact factor: 2.894

Review 2.  Elimination of visceral leishmaniasis on the Indian subcontinent.

Authors:  Om Prakash Singh; Epco Hasker; Marleen Boelaert; Shyam Sundar
Journal:  Lancet Infect Dis       Date:  2016-09-28       Impact factor: 25.071

3.  Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain.

Authors:  Sarah Hendrickx; Annelies Leemans; Annelies Mondelaers; Suman Rijal; Basudha Khanal; Jean-Claude Dujardin; Peter Delputte; Paul Cos; Louis Maes
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

4.  Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.

Authors:  Sarfaraz Ahmad Ejazi; Pradyot Bhattacharya; Md Asjad Karim Bakhteyar; Aquil Ahmad Mumtaz; Krishna Pandey; Vidya Nand Ravi Das; Pradeep Das; Mehebubar Rahaman; Rama Prosad Goswami; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2016-10-14

5.  Microbial protein targets: towards understanding and intervention.

Authors:  Paul W Denny
Journal:  Parasitology       Date:  2017-11-16       Impact factor: 3.234

Review 6.  Evaluating drug resistance in visceral leishmaniasis: the challenges.

Authors:  S Hendrickx; P J Guerin; G Caljon; S L Croft; L Maes
Journal:  Parasitology       Date:  2016-11-21       Impact factor: 3.234

Review 7.  Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform.

Authors:  Jacob T Bush; Monique Wasunna; Fabiana Alves; Jorge Alvar; Piero L Olliaro; Michael Otieno; Carol Hopkins Sibley; Nathalie Strub Wourgaft; Philippe J Guerin
Journal:  PLoS Negl Trop Dis       Date:  2017-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.